FUJIFILM Group IR Pickup

The information in IR Pickup is current at the time of the release.
Note that the information shown here may not be latest information (termination of production or sales, changes to specifications or pricing, organizational or contact address changes, etc.), and may be subject to change without prior notice.

Latest IR Pickup

Life Sciences
Released on Jan. 16, 2014

Photo imaging business, which provides photographic-related products, was one of the Fujifilm’s main businesses since the Company’s establishment and accounted for a large proportion of sales. However, the spread of digital cameras that occurred from 2000 led to a sharp decline in sales of photographic film, a main product at that time. Facing this rapid change in its business environment, Fujifilm has swiftly undertook bold measures that meet this change and succeeded in establishing a stable business foundation. Today, the photo imaging business focuses on high-value-added printing services using high-quality photographic color paper, which has a high market share, as well as actively conducts measures that increase printing demand itself.

Imaging Solutions

Photo Imaging
Released on Jan. 16, 2014

Photo imaging business, which provides photographic-related products, was one of the Fujifilm’s main businesses since the Company’s establishment and accounted for a large proportion of sales. However, the spread of digital cameras that occurred from 2000 led to a sharp decline in sales of photographic film, a main product at that time. Facing this rapid change in its business environment, Fujifilm has swiftly undertook bold measures that meet this change and succeeded in establishing a stable business foundation. Today, the photo imaging business focuses on high-value-added printing services using high-quality photographic color paper, which has a high market share, as well as actively conducts measures that increase printing demand itself.

Optical Device / Electronic Imaging
Nov. 14, 2012

Fujifilm's optical device business is a division that manufactures, markets, researches, and develops various types of high-performance lenses. The business has, so far, provided FUJINON brand products in various fields. To achieve further growth, the business will provide high-value-added products with higher specification, while reinforcing its manufacturing capacity to meet the demand in emerging countries, where growth is expected.

Photo Imaging
Released on Feb. 7, 2012

In 1998, FUJIFILM released a revolutionary new type of instant camera named instax mini. More than a decade had passed since its release and the digitalization is proceeding, but this instax mini is still achieving a high reputation, mainly from women. In recent years, instax mini's positive aspects have spread in East Asia, and its popularity is skyrocketing on a level where its production cannot reach the demand.

Optical Device / Electronic Imaging
Nov. 10, 2011

On October 5, 2011, FUJIFILM announced the release of FUJIFILM X10, a new premium compact digital camera. By launching high-value-added models into a digital camera market experiencing severe competition, FUJIFILM aims to achieve a brand image with a high reputation of high respect and high image quality and to increase its revenues.

Optical Device / Electronic Imaging
Sep. 30, 2009

FUJIFILM has been developing digital cameras that can reproduce natural image qualities as people see them. In this process, FUJIFILM's high imaging technologies and know-how, cultivated as a manufacturer of photographs, were fully used. As a result, FUJIFILM succeeded in developing the Super CCD EXR sensor and the FinePix REAL 3D System.
These proprietary technologies are the source of FUJIFILM's competitiveness.

Information Solutions

Healthcare
Sep. 4, 2013

With fewer side effects and high efficacy, high market growth is expected for biopharmaceuticals, and the Group is promoting the development of antibody drugs in this field. Anticancer drug FF-21101 is a drug candidate that is being developed especially by utilizing Group synergies, and clinical trials in the United States are scheduled to start in 2014.

Industrial Materials / Electronic Materials&Others
May 22, 2013

Fujifilm was the first to succeed in the digitalization of X-ray photographs, which led to the development of the world's first medical-use X-ray diagnostic imaging system Fuji Computed Radiography (FCR) in 1983. This FCR is used not only for medical inspections, but also for inspections for the aerospace, automotive, such structures as petroleum plants, and metal materials and contributes to the early detection of defects that might lead to serious accidents.

Industrial Materials / Electronic Materials&Others
Jan. 12, 2011

In December 2010, FUJIFILM turned the semiconductor CMP slurry manufacturer/distributor US-based Planner Solutions, LLC into one of its wholly owned subsidiaries. FUJIFILM will further expand the electronic materials business, making further contributions to the development of the semiconductor devices industry.

Flat Panel Display Materials
Sep. 28, 2010

Flat panel display (FPD) materials business, which provides film for liquid crystal displays (LCD) and is one of the core businesses of FUJIFILM, is skyrocketing due to an increase in worldwide demand for LCD TVs. To meet this demand, FUJIFILM announced expansion in production capability of film for LCDs in July 2010.

Healthcare
Jul. 15, 2010

In April 2010, FUJIFILM Pharma Co., Ltd., a consolidated subsidiary of FUJIFILM established to build a base of development and marketing of pharmaceuticals business, started its operations. Generic drugs with the FUJIFILM brand came into existence.

Healthcare
Mar. 29, 2010

If IT networks are built from highly advanced medical institutes to general hospitals and clinics on isolated islands, patients would be able to receive advanced medical treatment more easily. FUJIFILM is working to build this medical IT network, achieving the top share of PACS in the domestic market and in the third group in the US.

Healthcare
Dec. 7, 2009

In October 2009, Toyama Chemical started the third and final phase of clinical trials in Japan for the T-705 anti-influenza agent, which boasts a different mechanism from other anti-influenza agent and has high expectations for its production from the public. Toyama Chemical, cooperating with FUJIFILM, is accelerating the development of the drug for early release.

Healthcare
Jun. 26, 2008

FUJIFILM Holdings Corporation made Toyama Chemical Co., Ltd. a consolidated subsidiary in March 2008, and entered the pharmaceuticals field. Due to this entry, the Group's business field expanded from diagnosis and prevention to treatment. From now on, the Group will expand further to be a comprehensive healthcare company.

Healthcare
Jun. 26, 2008

Until now, FUJIFILM's medical business focused on diagnostic imaging systems that capture the internal parts of our body.
Considering the recent growing trend toward a healthy life, the answer to the question, “What can the Group do using its core technologies?” was “entering the healthcare business.”

Document Solutions

Global Services
Jul. 5, 2012

When clients operate their businesses, a number of documents are used as communications tools, including catalogs, direct mail, all types of manuals, accounts, application forms, and contracts. These are all core documents that are necessary for business operations. Fuji Xerox's global service is a document outsourcing service that provides optimal business communications and additional value to clients and users.

Office Printers
Apr. 22, 2011

In November 2010, Fuji Xerox launched a series of compact A4 printer/multifunction devices and has installed various cutting-edge technologies. This series will focus on volumes in small and medium-sized overseas offices and emerging countries, making a full entry into these markets.

Office Products
Feb. 27, 2009

By collaborating with the customer's various critical business systems, Fuji Xerox's multifunction device offers new value by being the terminal, directly promoting the customer's business efficiency and product quantities.